Universe Pharmaceuticals Inc (UPC)
2.15
-0.02
(-0.92%)
USD |
NASDAQ |
May 03, 16:00
2.03
-0.12
(-5.58%)
After-Hours: 20:00
Universe Pharmaceuticals Cash from Operations (TTM): 1.120M for Sept. 30, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| September 30, 2023 | 1.120M |
| March 31, 2023 | -2.632M |
| September 30, 2022 | -1.312M |
| March 31, 2022 | 3.004M |
| September 30, 2021 | -2.056M |
| Date | Value |
|---|---|
| March 31, 2021 | -1.207M |
| September 30, 2020 | 6.115M |
| March 31, 2020 | 13.83M |
| September 30, 2019 | 13.20M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-2.632M
Minimum
Mar 2023
13.83M
Maximum
Mar 2020
3.341M
Average
1.120M
Median
Sep 2023
Cash from Operations (TTM) Benchmarks
| Sinovac Biotech Ltd | -- |
| CASI Pharmaceuticals Inc | -- |
| Zai Lab Ltd | -198.18M |
| I-MAB | -- |
| Gracell Biotechnologies Inc (DELISTED) | -- |